The landscape for the life sciences sector is both complex and exciting. You face many challenges – from cybersecurity threats and complex regulatory and policy environments, to cross-border complexities and increasing demands from stakeholders. At the same time, you are developing innovative products and services that are changing our world for the better. At Baker Newman Noyes (BNN) we work collaboratively with clients to navigate their unique challenges and identify opportunities to stay ahead of the curve. Our goal is to help you grow revenue and increase your market share. We have experience working with clients at all stages of development from start-ups to large multinational public entities. We serve a variety of life sciences companies, including those in the biotech, pharmaceutical, medical device, and other emerging sectors.
Our professionals actively participate in trade associations such as the Massachusetts High Technology Council, the New Hampshire High Technology Council, and the Maine International Trade Center. This involvement ensures our life sciences team is engaged and on top of the issues you are facing.
Life sciences companies turn to BNN for help with:
- Audit and Assurance, Including A133 Grant Audits (required for federal funding exceeding $500K)
- Complex tax accounting issues under ASC 740
- Internal audit & enterprise risk management
- International tax, including transfer pricing
- Massachusetts Life Science Center’s (“MLSC”) Tax Incentive Program
- Mergers & acquisitions advisory
- R&D tax credits
- Revenue Recognition
- Sarbanes-Oxley compliance
- SEC Reporting
- SSAE 16 and Service Organization Control Reports
- Technology risk management
In addition, through our membership of Baker Tilly International, we are able to provide premier accounting, assurance, tax and specialist business advice worldwide, drawing on internationally recognized industry and service line experts in 147 countries.
Related Resources (Read More in Our Library)
- Tangible Property Regulations: The Safe Harbors
- Research and Development Credit Explained
- A New Spin on the R&D Tax Credit for Small Start-Ups
- Transfer Pricing: Why You Should Care
Mark joined Baker Newman Noyes in 2014 as the principal-in-charge of the firm’s Boston office. He focuses primarily on serving clients in the commercial and consumer products industries, with a special concentration in the retail, e-commerce and medical device sectors.
Bob Croak is a principal of the firm, providing tax advisory services to a broad range of clients with a special focus on the cleantech, life sciences, technology, and manufacturing, distribution and retail sectors.